| abstract |
Complexes of bismuth, e.g. bismuth salts, and polyacrylate, e.g. carbomer, are disclosed which may be incorporated into pharmaceutical compositions for oral, oral delayed-release, and rectal administration. The complexes may be combined with an antibiotic, such as tetracycline, and an antiprotozoal agent, e.g. Metronidazole, for use in the treatment of $i(Helicobacter pylori) infection. The treatment of inflammatory bowel disease using bismuth/polyacrylate complexes, or other bismuth preparations, is also described. |